Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-107637
Filing Date
2024-12-11
Accepted
2024-12-11 07:25:25
Documents
109
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0224125-10q_rafael.htm   iXBRL 10-Q 1347186
2 CERTIFICATION ea022412501ex31-1_rafael.htm EX-31.1 7669
3 CERTIFICATION ea022412501ex31-2_rafael.htm EX-31.2 7617
4 CERTIFICATION ea022412501ex32-1_rafael.htm EX-32.1 3891
5 CERTIFICATION ea022412501ex32-2_rafael.htm EX-32.2 3880
  Complete submission text file 0001213900-24-107637.txt   10297371

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rfl-20241031.xsd EX-101.SCH 108693
7 XBRL CALCULATION FILE rfl-20241031_cal.xml EX-101.CAL 77804
8 XBRL DEFINITION FILE rfl-20241031_def.xml EX-101.DEF 568541
9 XBRL LABEL FILE rfl-20241031_lab.xml EX-101.LAB 960740
10 XBRL PRESENTATION FILE rfl-20241031_pre.xml EX-101.PRE 579327
112 EXTRACTED XBRL INSTANCE DOCUMENT ea0224125-10q_rafael_htm.xml XML 1187447
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-38411 | Film No.: 241540137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)